<DOC>
	<DOCNO>NCT00004854</DOCNO>
	<brief_summary>We would like see use Carvedilol adjunct Ace inhibitor increase ejection fraction heart echo . All interpretation data send Boston Children 's Hospital review , primary research center study . There 5 hospital participate study . The population target child moderate heart failure must Ace inhibitor time enrollment . Our outcome placing Carvedilol change ejection fraction echo . The patient see every 1-2 week , titrate medication maintenance dose . Secondary outcome increase quality life , exercise tolerance decrease symptom score note questionnaire .</brief_summary>
	<brief_title>The Safety Efficacy Adjunct Carvedilol Children With Moderate Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<criteria>Etiology heart failure Group 1 Group 2 Moderate heart failure evidence ventricular shorten fraction &lt; = standard deviation mean , ejection fraction &lt; = 40 % ) document shorten fraction ejection fraction meet criterion great 3 month Standard medical therapy include ACE inhibitor plus minus diuretic plus minus digoxin ; effort make maximize therapy prior entry . Medication dose must stable 3 month prior entry Willingness comply followup test</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>December 2003</verification_date>
	<keyword>moderate heart failure</keyword>
</DOC>